$TWST
Twist Bioscience Corp
PRICE
$37 ▼-0.216%
Extented Hours
VOLUME
911,462
DAY RANGE
35.14 - 37.25
52 WEEK
25.07 - 139.99
Key Metrics
Market Cap
2.09 B
Beta
2.20
Avg. Volume
1.35 M
Shares Outstanding
56.26 M
Yield
0%
Public Float
0
Next Earnings Date
2022-08-05
Next Dividend Date
Company Information
Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by 'writing' DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.
CEO: Emily Leproust
Website: www.twistbioscience.com
HQ: 681 Gateway Blvd. South San Francisco, 94080 California
Related News